Medexus Pharmaceuticals Inc. (MDP.TO)
Distributes specialty pharmaceuticals for allergies, arthritis, cancer, and rare blood disorders across North America.
4.81-0.01%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+80.8%
The outlook
MDP.TO is trading above both its 50- and 200-day moving averages, positioned well into its 52-week range near the upper end. Analysts see meaningful upside, with an average price target about 42% above the current level. The overall data leans bullish based on current technicals and analyst sentiment.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range84% of the way from its 52-week low to high
Price targetAvg target +42% vs current price
Analyst price target
~12-month · 5 analysts6.81average target+41.6% vs now
Now 4.81
Low 5.55High 8.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$152.3M
52-wk high
5.25
52-wk low
2.47
50-day avg
4.44
200-day avg
3.42
Trailing P/E
—